会议签到 大会名称 | 第五届 中 国合成生物学及生物制造大会暨Life China第三届功能食品与营养科学大会 签到地点 | 杭州市-和达希尔顿逸林酒店 签到时间 | 2026年 3月31日/4月1日 8:00开始签到 （请在完成签到后随身佩戴参会证，它是您参会的唯一有效证件，请妥善保管，遗失不补。） 大会地址 | 浙江省杭州市钱塘区金沙大道600号 立即扫码 免费 报名参会 免费送餐券 转发此文章链接到朋友圈 无分组并 保留48小时以上 限量150份， 签到时凭朋友圈转发界面领取（限1张） （ 备注： 数量有限， 先到先得 ） 现大会主办方特别推出 "转发领手册" 活动！ 连续 4天转发本文或报名小程序 至朋 友圈 ，大会现场签到时出示集赞页面， 即可在签到处免费领取500页 《中国生物制 造产业政策汇编》 一本 数量有限，先到先得 杭州萧山国际机场—杭州和达希尔顿逸林酒店 打车： 28公里 约40分钟 公交车： 1号线，杭州萧山国际机场-金沙湖地铁站 B口 ，约 50分钟 参会指南 PART 0 1 交通指南 杭州东站—杭州和达希尔顿逸林酒店 杭州东站 杭州和达希尔顿逸林酒店 打车： 15公里 约25分 ...

签到地点 | 杭州市-和达希尔顿逸林酒店 签到时间 | 2026年 3月31日/4月1日 8:00开始签到 （请在完成签到后随身佩戴参会证，它是您参会的唯一有效证件，请妥善保管，遗失不补。） 会议签到 大会名称 | 第五届 中 国合成生物学及生物制造大会暨Life China第三届功能食品与营养科学大会 大会地址 | 浙江省杭州市钱塘区金沙大道600号 立即扫码 免费 报名 免费送餐券 转发此文章链接到朋友圈 无分组并 保留48小时以上 限量150份， 签到时凭朋友圈转发界面领取（限1张） （ 备注： 数量有限， 先到先得 ） 现大会主办方特别推出 "转发领手册" 活动！ 连续 4天转发本文或报名小程序 至朋友圈 ，大会现场签到时出示集赞页面， 即可在签到处 免费领取500页 《中国生物制造产业政策汇编》 一本 数量有限，先到先得 会议指南 | PART 0 1 | 交通指南 | | | --- | --- | --- | | 杭州东站—杭州和达希尔顿逸林酒店 | | | | 打车： 15公里 约25分钟 | | | | 地铁： 1号线，杭州东站-金沙湖地铁站B口，约30分钟 | | | | 杭州萧山国际机场 ...

会议签到 大会名称 | 第五届 Synbio China杭州站 中国合成生物学及生物制造大会暨Life China第三届功能食品与营养科学大会 签到地点 | 杭州市-和达希尔顿逸林酒店 签到时间 | 2026年 3月31日/4月1日 8:00开始签到 （请在完成签到后随身佩戴参会证，它是您参会的唯一有效证件，请妥善保管，遗失不补。） 大会地址 | 浙江省杭州市钱塘区金沙大道600号 立即扫码 免费 报名 PART 0 1 交通指南 杭州东站—杭州和达希尔顿逸林酒店 打车： 15公里 约25分钟 地铁： 1号线，杭州东站-金沙湖地铁站B口，约30分钟 杭州萧山国际机场—杭州和达希尔顿逸林酒店 打车： 28公里 约40分钟 公交车： 1号线，杭州萧山国际机场-金沙湖地铁站 B口 ，约 50分钟 住宿指南 PART 0 2 杭州和达希尔顿逸林酒店（会议酒店） 基础房型及价格： 逸林大床/双床 550/间夜含早 地址：浙江省杭州市钱塘区下沙街道金沙大道 600 号，联系电话 0571-89898888 杭州金沙湖假日酒店 参考房型及价格：大床238元/间夜；双床280元/间夜，不含早 免费送餐券 转发此文章链接到朋友 ...

JUST IN: $PHA pumps 40.6% after being listed on Bithumb. https://t.co/eqyiwLIutE ...

DT产业研究院 | 人物专访 | 微构工场董事长 徐绚明 摘要 ： 离开西门子智能基础设施集团，徐绚明在生物制造的发酵罐里找到了新的战场，她的跨界不仅没减速，反而创造了3年建成万吨产线的行业新 纪录。在与DT新材料的交流中， 这位 "跨界者" 首次揭秘了微构工场如何破解PHA "有价无市" 的行业困局。 2025 年 12 月，湖北宜昌万吨级 PHA 生产线正式投产。这条产线的建设方 —— 微构工场 ， 仅用 3 年就完成了从实验室到万吨级产业化的跨越， 刷新了资本效率新高度。不仅如此，微构工场也成为全球首个获得BPI家庭堆肥PHA原料认证、首家实现中美欧食品接触级 PHA 产品同步销售的企 业。 而带领这家合成生物"明星企业"高速发展的掌舵人徐绚明，此前有 15 年西门子 智能基础设施集团 的从业经历。 2022 年底，她跨界掌舵微构工场，用 "市场导向" 的逻辑改写了 PHA 研发与产业化的节奏。 这位 "跨界者" 如何破解生物基材料 "有价无市" 的行 业困局？ 带着这个问题，DT新材料旗下 【SynBioCon】 、 【生物基能源与材料】 平台 与 徐绚明展开了长达90分钟的对话，首次揭开PHA成功商 ...

Core Viewpoint - The article emphasizes the importance of bio-based chemicals and materials as a key pillar of the bio-manufacturing industry, highlighting their potential to replace traditional petroleum-based products in various sectors such as packaging, textiles, and automotive, thus contributing to global green transformation and carbon neutrality goals [2]. Event Details - The "5th China Synthetic Biology and Bio-Manufacturing Conference" will be held in Hangzhou from March 31 to April 1, 2026, focusing on bio-based chemicals and materials [2][3]. - The conference aims to gather insights from academia, industry, and research to promote high-quality development in the bio-based chemicals and materials sector [2]. Forum Setup - The conference will feature multiple sessions, including a dedicated session on bio-based chemicals and materials, with notable speakers such as Zhang Kechun from West Lake University and other industry leaders [7][8]. - The agenda includes discussions on synthetic biology-enabled new materials, low-cost production of high-performance PHA, and the development and application of furan bio-based materials [8][19][22]. Guest Speakers - Zhang Kechun, a professor at West Lake University, will present on synthetic biology's role in new materials [14]. - Lan Yuxuan, co-founder of Beijing Microstructure Bio-Tech Co., will discuss next-generation industrial biotechnology for low-cost PHA production [16]. - Luo Zhao, Vice President of Lif Bio, will cover the research and application of furan bio-based materials [19]. - Zhou Wenzhi, founder and CEO of Jiangsu Sanmu Biotechnology Co., will address the industrialization of starch-based bio-manufacturing driven by synthetic biology [22]. Business Cooperation - The conference offers various exhibition opportunities for companies involved in synthetic biology and modern biotechnology applications, including sponsorship and promotional options [24].

基于此， 2026年3月31日-4月1日 ，"第五届中国合成生物学及生物制造大会"将在杭州举办，其中设置 【 生物基化学品与材料专场】 ，旨在汇聚产学研 用多方智慧，助力生物基化学品与材料产业高质量发展。 大会时间 | 2026年3月31日-4月1日 大会地点 | 杭州-和达希尔顿逸林酒店 大会规模 | 1000人 主办单位 | synbio深波 承办单位 | 享融智云 媒体支持 | synbio新农食、synbio新美护、synbio新材料、生物制造圈、合成生物学俱乐部 立即扫码 免费 报名 大会介绍 0 1 论坛设置 0 2 | | 会场一 | 会场二 | 会场三 | | --- | --- | --- | --- | | Day1 AM | | 新增长 · 新突破:生物制造产业生态大会 | | | | Life China第三届功能 食品与营养科学大会 | 生物制造产业应用大会 | 生物制造技术与工艺大会 | | Day1 PM | 药食同源专场 | 功效护肤专场 | Al+生物制造专场 | | Day2 AM | 功能原料与生物制造专场 | | 生物制造工艺专场 | | Day2 PM | 未来食品与 ...

Core Insights - The biobased materials manufacturing industry is projected to grow by 27.9% by 2025, with biobased chemical fiber production expected to increase by 19.5% [2] - PLA and PHA are identified as key solutions for replacing traditional petroleum-based plastics, playing a crucial role in global green transformation [2] Group 1: PLA Insights - Global PLA production capacity has surpassed 3 million tons per year, with China leading at 1.2 million tons per year [3] - Major Chinese companies like Anhui Fengyuan and Jindan Technology are rapidly expanding their capacities [3] - However, 80% of the technology for producing lactide is dependent on the US company NatureWorks, and the cost of core production equipment has increased by 220% [3] Group 2: PHA Insights - PHA is overcoming scale limitations through technological innovations, with Tsinghua University's Yichang PHA production base set to produce 10,000 tons per year, expanding to 30,000 tons [4] - The production cost of PHA is expected to drop by 40% to 30,000 yuan per ton due to advancements in extreme halophilic bacteria technology [4] - Despite these advancements, PHA faces challenges such as low actual production (less than 50,000 tons) compared to planned capacity (over 500,000 tons) [5] Group 3: Industry Challenges - The industry is facing issues with "pseudo-degradation" plastics, with only 7.3% marine degradation rate for PBAT, highlighting the need for stricter standards [5] - The cost of biobased materials follows a "10x rule," where costs can escalate significantly from lab to industrial scale, impacting production viability [6] - Supply chain bottlenecks exist, with domestic lactide self-sufficiency below 30% and reliance on foreign patents for core bacterial strains [7] Group 4: Pathways to Resolution - The focus on "non-grain" and "high-value" targets for PHA could reshape market dynamics, with applications in medical sutures and high-end packaging [8] - Collaborative models are emerging, such as Anhui Fengyuan's integrated supply chain reducing raw material costs by 40% [10] - Policy innovations are needed to shift from short-term subsidies to sustainable mechanisms that foster innovation and market growth [11] Group 5: Future Projections - By 2035, PLA is expected to become a major alternative to traditional plastics, potentially capturing 50% of the market in packaging and textiles [12] - PHA is likely to split into two application tracks: low-end markets utilizing waste materials and high-end markets in medical applications [12]

BULLISH: $PHA SURGES 68% IN 24 HOURS TO LEAD ALTCOIN GAINERS@PhalaNetwork ($PHA), a decentralized compute platform using Trusted Execution Environments (TEEs) for privacy-preserving AI and DePIN workloads, saw trading volume hit $123M–$161M amid strong sector rotation into confidential AI infrastructure.Following its 2025 migration to Ethereum L2, the project powers verifiable, hardware-secured AI models and has integrations with NEAR, Sentient AGI, and more.Social metrics (Galaxy Score near highs) reflect ...

Core Viewpoint - Watson Bio announced the establishment of the Yunnan Chuangwo Biological Industry Investment Fund in collaboration with several partners, focusing on synthetic biology and biotechnology sectors [2][5]. Group 1: Fund Details - The target scale of the fund is 1 billion RMB, with Watson Bio contributing 450 million RMB as a limited partner [3]. - The partners and their contributions are as follows: - Guotou Chuangyi Industrial Fund Management Co., Ltd.: 1 million RMB (0.10%) - Central Enterprise Rural Industry Investment Fund Co., Ltd.: 299 million RMB (29.90%) - Yunnan Watson Biotechnology Co., Ltd.: 450 million RMB (45.00%) - Yuxi State-owned Capital Operation Co., Ltd.: 250 million RMB (25.00%) [4]. - The capital will be contributed in three phases: 300 million RMB for the first phase, 300 million RMB for the second phase, and 400 million RMB for the third phase [4]. Group 2: Investment Focus - The fund's core investment direction focuses on synthetic biology, biological manufacturing, and related biotechnology industries [5]. - Specific investment areas include but are not limited to: - Synthetic biology (enzyme preparations, amino acids, probiotics) - Life and health (plant extracts, recombinant collagen, sweeteners, protein drugs) - Biological agriculture (feed protein, micro-ecological preparations, animal vaccines, biological nitrogen fixation) - Bioenergy (bioethanol, biodiesel) - Biomaterials (PLA, PHA, PDO) - Technology platform enterprises (strain development, AI protein design) - High-throughput equipment (microfluidic devices, gene sequencing equipment) [5].